Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP541537.RAbW5vQfxULQ-MVc7er7YJwz-h1N3UlVpX9N4Z8a2mv1I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP541537.RAbW5vQfxULQ-MVc7er7YJwz-h1N3UlVpX9N4Z8a2mv1I130_assertion type Assertion NP541537.RAbW5vQfxULQ-MVc7er7YJwz-h1N3UlVpX9N4Z8a2mv1I130_head.
- NP541537.RAbW5vQfxULQ-MVc7er7YJwz-h1N3UlVpX9N4Z8a2mv1I130_assertion wasGeneratedBy ECO_0000203 NP541537.RAbW5vQfxULQ-MVc7er7YJwz-h1N3UlVpX9N4Z8a2mv1I130_provenance.
- NP541537.RAbW5vQfxULQ-MVc7er7YJwz-h1N3UlVpX9N4Z8a2mv1I130_assertion wasDerivedFrom befree-20140225 NP541537.RAbW5vQfxULQ-MVc7er7YJwz-h1N3UlVpX9N4Z8a2mv1I130_provenance.
- NP541537.RAbW5vQfxULQ-MVc7er7YJwz-h1N3UlVpX9N4Z8a2mv1I130_assertion SIO_000772 12242461 NP541537.RAbW5vQfxULQ-MVc7er7YJwz-h1N3UlVpX9N4Z8a2mv1I130_provenance.
- NP541537.RAbW5vQfxULQ-MVc7er7YJwz-h1N3UlVpX9N4Z8a2mv1I130_assertion evidence source_evidence_literature NP541537.RAbW5vQfxULQ-MVc7er7YJwz-h1N3UlVpX9N4Z8a2mv1I130_provenance.
- NP541537.RAbW5vQfxULQ-MVc7er7YJwz-h1N3UlVpX9N4Z8a2mv1I130_assertion description "[Ac-GIP and pGlu-GIP, show resistance to plasma dipeptidylpeptidase IV degradation, resulting in enhanced biological activity and improved antidiabetic potential in vivo, raising the possibility of their use in therapy of Type II (non-insulin-dependent) diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541537.RAbW5vQfxULQ-MVc7er7YJwz-h1N3UlVpX9N4Z8a2mv1I130_provenance.